12 Statistics on Physician & ASC Reimbursement for Polypectomy Procedures

Gastroenterology and Endoscopy

Share on Facebook
Here are 12 statistics on ambulatory surgery center and physician Medicare payments for gastroenterology/endoscopy procedures involving polypectomy, according to Boston Scientific's 2014 Coding & Payment Quick Reference Select Polypectomy Procedures report.

Procedure and CPT Code

Colonoscopy through stroma with removal of tumor(s), polyp(s) or other lesion(s) by hot biopsy forceps or bipolar cautery (44392)

Physician payment in facility: $226
ASC facility payment: $407

Colonoscopy, flexible, proximal to splenic flexure with removal of tumor(s), polyp(s) or other lesion(s) by hot biopsy forceps or bipolar cautery (45384)

Physician payment in facility: $277
ASC facility payment: $407

Sigmoidoscopy, flexible, with removal of tumor(s), polyp(s) or other lesion(s) by hot biopsy forceps or bipolar cautery (45333)

Physician payment in facility: $113
ASC facility payment: $255  

Colonoscopy through stroma with removal of tumor(s), polyp(s) or other lesion(s) by snare technique (44394)

Physician payment in facility: $263
ASC facility payment: $407

Colonoscopy, flexible, proximal to splenic flexure with removal of tumor(s), polyp(s) or other lesion(s) by snare technique (45385)

Physician payment in facility: $315
ASC facility payment: $407

Sigmoidoscopy, flexible, with removal of tumor(s), polyp(s) or other lesion(s) by snare technique (45338)

Physician payment in facility: $145
ASC facility payment: $431

CPT copyright 2014 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.

More Articles on Gastroenterology:
Gastroenterologists & Primary Care Physicians: How to Build Meaningful Relationships
4 GI/Endoscopy Devices Receive FDA 510(k) Clearance in April
11 Statistics on Endoscopy Procedures & Diagnoses in the U.S.

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

Salix Pharmaceuticals could be acquired for $190 per share

Read Now